Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Health Care / Hospitals

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 6

UNESCO announces winners of 2017 International Research in the Life Sciences Prize
UNESCO announces winners of 2017 International Research in the Life Sciences Prize
7/24/2017 4:20:37 PM
The Director-General of UNESCO, Irina Bokova, has announced the laureates of the  UNESCO–Equatorial Guinea International Prize for Research in the Life Sciences  for 2017.
UNICEF thanks the State of Kuwait for its support to Yemen’s children
UNICEF thanks the State of Kuwait for its support to Yemen’s children
7/24/2017 4:15:31 PM
As the humanitarian crisis in Yemen deepens and with no end in sight, UNICEF welcomes the latest contribution of over US$2 million from the State of Kuwait to support children affected by the acute watery diarrhoea /cholera outbreak.
GSK submits US regulatory filing of Arnuity Ellipta in children with asthma
GSK submits US regulatory filing of Arnuity Ellipta in children with asthma
7/24/2017 4:03:42 PM
Arnuity Ellipta (fluticasone furoate 100mcg and 200mcg) is an inhaled corticosteroid (ICS) which was approved in the US in August 2014 for the maintenance treatment of asthma in patients aged 12 years and older.
Pfizer Announces Positive Top-Line Results from The Comparative Reflections B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin®1 (bevacizumab)
Pfizer Announces Positive Top-Line Results from The Comparative Reflections B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin®1 (bevacizumab)
7/24/2017 3:11:20 PM
Pfizer Inc. (NYSE:PFE) today announced that the REFLECTIONS B7391003 study, a comparative, confirmatory safety and efficacy study of PF-06439535 versus Avastin® (bevacizumab), met its primary objective.
Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen
Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen
7/24/2017 12:34:00 PM
Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today announced that a regimen of two investigational long-acting, injectable formulations of HIV medicines —Janssen’s rilpivirine and ViiV Healthcare’s cabotegravir — given together every 4 or 8 weeks was as effective as 3-drug oral antiretroviral therapy (ART) at …
EMLab P&K’s Seattle Area Laboratory Celebrates 13 years, Supporting Washington with Local Mold Analysis
EMLab P&K’s Seattle Area Laboratory Celebrates 13 years, Supporting Washington with Local Mold Analysis
7/24/2017 11:32:33 AM
EMLab P&K, a TestAmerica company and the leading commercial indoor air quality (IAQ) laboratory in North America, marks thirteen years of serving communities throughout Washington.
Research Shows One Aspect of the Affordable Care Act Has No Significant Impact on Emergency Department Patient Visits
Research Shows One Aspect of the Affordable Care Act Has No Significant Impact on Emergency Department Patient Visits
7/24/2017 9:36:34 AM
As the debate surrounding the Affordable Care Act (ACA) looms in the U.S. Congress, Johns Hopkins researchers are weighing in on one aspect of the law.
Philips’ Second Quarter Results 2017
Philips’ Second Quarter Results 2017
7/24/2017 8:47:50 AM
Second-quarter highlights • Sales increased to EUR 4.3 billion, with comparable sales growth of 4%; comparable order intake increased 8% compared to Q2 2016 • Net income from continuing operations amounted to EUR 161 million, compared to EUR 118 million in Q2 2016 • Adjusted EBITA improved 15% to EUR 439 million, or 10.2% of sales, compared to EUR 383 million, or …
California Hospital’s Surgical Unit Closed Due to Mold
California Hospital’s Surgical Unit Closed Due to Mold
7/24/2017 8:24:18 AM
In June,  Sonoma West Times & News  published a story about the temporary closure of a surgical unit at a hospital in Sonoma County. According to the report, mold was detected around a sterilization sink.
EMA’s CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA’s CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
7/24/2017 7:37:46 AM
Merck KGaA, Darmstadt,  Germany, which operates its biopharmaceutical business as EMD Serono in the US and  Canada, and Pfizer Inc. (NYSE:  PFE ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of avelumab* (BAVENCIO ® ) as a monotherapy for the treatment of adult patients …
Best Selling Book, “The Second Start,” Is Now Free on Amazon for 5 Days 
(until 07/28/2017)
Best Selling Book, “The Second Start,” Is Now Free on Amazon for 5 Days (until 07/28/2017)
7/24/2017 6:00:00 AM
Best Seller Publishing announces the release of Tammy Lee Schumacher’s new book, “The Second Start: Finding Joy in the New You.” It will be available for free download in the Amazon Kindle Store on July 24th.
Tammy Lee Schumacher’s “The Second Start” - Free Download Tomorrow (07/24/2017)
Tammy Lee Schumacher’s “The Second Start” - Free Download Tomorrow (07/24/2017)
7/23/2017 6:00:00 AM
Best Seller Publishing announces the release of Tammy Lee Schumacher’s new book, “The Second Start: Finding Joy in the New You.” It will be available for free download in the Amazon Kindle Store on July 24th.
COX-2 Inhibitors May Reverse IDO1-mediated Immunosuppression in Some Cancers
COX-2 Inhibitors May Reverse IDO1-mediated Immunosuppression in Some Cancers
7/21/2017 8:40:10 PM
In preclinical studies, tumors that consitutively expressed the protein indoleamine 2,3-dioxygenase (IDO1) responded to the cyclooxygenase-2 (COX-2) inhibitor celecoxib (Celebrex) and had improved infiltration of certain subsets of T cells, making them more likely to respond to anti-PD1 therapies, according to data published in Cancer Immunology Research, a journal of the …
Small Survey: Most Primary Care Physicians Can’t Identify All Risk Factors for Prediabetes
Small Survey: Most Primary Care Physicians Can’t Identify All Risk Factors for Prediabetes
7/21/2017 6:32:31 PM
Johns Hopkins researchers who distributed a survey at a retreat and medical update for primary care physicians (PCPs) report that the vast majority of the 140 doctors who responded could not identify all 11 risk factors that experts say qualify patients for prediabetes screening.
GSK submits EU filing for extended use of Relvar Ellipta in patients with controlled asthma on an ICS/LABA combination
GSK submits EU filing for extended use of Relvar Ellipta in patients with controlled asthma on an ICS/LABA combination
7/21/2017 1:32:48 PM
FF/VI is currently indicated in Europe for the regular treatment of patients aged 12 and over with asthma who are not adequately controlled on both ICS and ’as-needed’ short-acting β2-agonist (SABA) and where use of a combination product (ICS and LABA) is appropriate.
Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis
Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis
7/21/2017 12:45:59 PM
  Sanofi  and  Regeneron Pharmaceuticals, Inc.  today announced that the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the marketing authorization of Dupixent® (dupilumab), recommending its approval in Europe for use in adults with moderate-to-severe atopic dermatitis  who are candidates for systemic …
Roche gains positive CHMP opinion for Actemra / RoActemra in giant cell arteritis
Roche gains positive CHMP opinion for Actemra / RoActemra in giant cell arteritis
7/21/2017 12:27:19 PM
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of Actemra®/RoActemra® (tocilizumab) for the treatment of giant cell arteritis (GCA), a chronic and potentially life-threatening autoimmune condition.
Chief Business Leader of Philips’ Personal Health businesses Pieter Nota to leave company
Chief Business Leader of Philips’ Personal Health businesses Pieter Nota to leave company
7/21/2017 10:46:29 AM
Royal Philips (NYSE:PHG, AEX: PHI) today announced that Pieter Nota, Chief Business Leader of Philips’ Personal Health businesses and Chief Marketing Officer will be leaving the company to assume responsibility for sales and brand BMW on the Board of Management of BMW AG per January 1, 2018.
FDA clears first neonatal magnetic resonance imaging device
FDA clears first neonatal magnetic resonance imaging device
7/20/2017 2:11:01 PM
Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).
Denver Testing Laboratory to Host a FREE IAQ, Mold, Bacteria and Legionella Sampling Workshop
Denver Testing Laboratory to Host a FREE IAQ, Mold, Bacteria and Legionella Sampling Workshop
7/20/2017 12:09:54 PM
EMSL Analytical, Inc. is hosting a free Indoor Air Quality (IAQ), Mold, Bacteria and  Legionella  Sampling Workshop on Thursday, August 24th in Denver, Colorado.